FB2026_02 , released June 18, 2026
Reference Report
Open Close
Reference
Citation
Frolov, R.V., Singh, S. (2014). Celecoxib and ion channels: A story of unexpected discoveries.  Europ. J. Pharmacol. 730C(): 61--71.
FlyBase ID
FBrf0224577
Publication Type
Review
Abstract
Celecoxib (Celebrex), a highly popular selective inhibitor of cyclooxygenase-2, can modulate ion channels and alter functioning of neurons and myocytes at clinically relevant concentrations independently of cyclooxygenase inhibition. In experimental systems varying from Drosophila to primary mammalian and human cell lines, celecoxib inhibits many voltage-activated Na(+), Ca(2+), and K(+) channels, including NaV1.5, L- and T-type Ca(2+) channels, KV1.5, KV2.1, KV4.3, KV7.1, KV11.1 (hERG), while stimulating other K(+) channels-KV7.2-5 and, possibly, KV11.1 (hERG) channels under certain conditions. In this review, we summarize the information currently available on the effects of celecoxib on ion channels, examine mechanistic aspects of drug action and the concomitant changes at the cellular and organ levels, and discuss these findings in the therapeutic context.
PubMed ID
PubMed Central ID
Associated Information
Comments
Associated Files
Other Information
Secondary IDs
    Language of Publication
    English
    Additional Languages of Abstract
    Parent Publication
    Publication Type
    Journal
    Abbreviation
    Europ. J. Pharmacol.
    Title
    European Journal of Pharmacology
    Publication Year
    1967-
    ISBN/ISSN
    0014-2999
    Data From Reference
    Genes (1)
    Human Disease Models (1)